Baidu
map

Lancet:印度儿童及新生儿死亡负担研究-2000-2017

2020-05-22 MedSci原创 MedSci原创

尽管印度新生儿及婴幼儿得到疾病风险得到显著改善,但地区不平等的现象仍较为严重

过去几十年来,印度在改善儿童生存方面取得了重大进展,近日研究人员就印度各地方儿童死亡率变化趋势进行了考察。
 
研究分析了2000-17年间,印度每5×5 km范围内儿童5年死亡率(U5MR)和新生儿死亡率 (NMR) ,根据社会人口指数(SDI)将31个州和联邦分为三组。
 
印度每1000活产儿U5MR从2000年的83.1下降至2017年的42.4,NMR从38.0下降至23.5,但在低SDI地区,2017年,275 (88%)个地区的每1000名活产儿的U5MR在40以上,而291个(93%)地区,NMR在20以上。2010-17年间,各地方U5MR下降程度最大为9.02%,NMR下降程度最大为8.05%,其中低SDI的Odisha和Assam地区的改善最为显著,若这一趋势继续保持,印度将达成SDG 2030 U5MR目标,但未能达成SDG 2030 NMR和NHP 2025目标。2000-17年间,印度的儿童传染病下降幅度最高,新生儿疾病中等下降,先天性出生缺陷下降幅度最小。儿童和产妇营养不良是主要的危险因素,分别造成2017年68.2%的印度5岁以下儿童死亡和83.0%的新生儿死亡,10.8%的5岁以下儿童死亡可归因于不安全的水和卫生设施,8.8%可归因于空气污染。
 
研究认为,尽管印度新生儿及婴幼儿得到疾病风险得到显著改善,但地区不平等的现象仍较为严重。
 
原始出处:
 

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2061257, encodeId=ef0b206125ece, content=<a href='/topic/show?id=097063384db' target=_blank style='color:#2F92EE;'>#死亡负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63384, encryptionId=097063384db, topicName=死亡负担)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Sat May 30 13:19:54 CST 2020, time=2020-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813721, encodeId=a838813e2139, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 08:01:25 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830652, encodeId=45c81830652df, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Jan 30 04:19:54 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629910, encodeId=ce4616299100d, content=<a href='/topic/show?id=b7645849e55' target=_blank style='color:#2F92EE;'>#新生儿死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58497, encryptionId=b7645849e55, topicName=新生儿死亡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=450321383666, createdName=charleshjw, createdTime=Sun May 24 03:19:54 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1033794, encodeId=98281033e9485, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Fri May 22 15:19:54 CST 2020, time=2020-05-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2061257, encodeId=ef0b206125ece, content=<a href='/topic/show?id=097063384db' target=_blank style='color:#2F92EE;'>#死亡负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63384, encryptionId=097063384db, topicName=死亡负担)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Sat May 30 13:19:54 CST 2020, time=2020-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813721, encodeId=a838813e2139, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 08:01:25 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830652, encodeId=45c81830652df, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Jan 30 04:19:54 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629910, encodeId=ce4616299100d, content=<a href='/topic/show?id=b7645849e55' target=_blank style='color:#2F92EE;'>#新生儿死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58497, encryptionId=b7645849e55, topicName=新生儿死亡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=450321383666, createdName=charleshjw, createdTime=Sun May 24 03:19:54 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1033794, encodeId=98281033e9485, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Fri May 22 15:19:54 CST 2020, time=2020-05-22, status=1, ipAttribution=)]
    2020-08-27 14818eb4m67暂无昵称

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2061257, encodeId=ef0b206125ece, content=<a href='/topic/show?id=097063384db' target=_blank style='color:#2F92EE;'>#死亡负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63384, encryptionId=097063384db, topicName=死亡负担)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Sat May 30 13:19:54 CST 2020, time=2020-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813721, encodeId=a838813e2139, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 08:01:25 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830652, encodeId=45c81830652df, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Jan 30 04:19:54 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629910, encodeId=ce4616299100d, content=<a href='/topic/show?id=b7645849e55' target=_blank style='color:#2F92EE;'>#新生儿死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58497, encryptionId=b7645849e55, topicName=新生儿死亡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=450321383666, createdName=charleshjw, createdTime=Sun May 24 03:19:54 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1033794, encodeId=98281033e9485, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Fri May 22 15:19:54 CST 2020, time=2020-05-22, status=1, ipAttribution=)]
    2021-01-30 howi
  4. [GetPortalCommentsPageByObjectIdResponse(id=2061257, encodeId=ef0b206125ece, content=<a href='/topic/show?id=097063384db' target=_blank style='color:#2F92EE;'>#死亡负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63384, encryptionId=097063384db, topicName=死亡负担)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Sat May 30 13:19:54 CST 2020, time=2020-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813721, encodeId=a838813e2139, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 08:01:25 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830652, encodeId=45c81830652df, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Jan 30 04:19:54 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629910, encodeId=ce4616299100d, content=<a href='/topic/show?id=b7645849e55' target=_blank style='color:#2F92EE;'>#新生儿死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58497, encryptionId=b7645849e55, topicName=新生儿死亡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=450321383666, createdName=charleshjw, createdTime=Sun May 24 03:19:54 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1033794, encodeId=98281033e9485, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Fri May 22 15:19:54 CST 2020, time=2020-05-22, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2061257, encodeId=ef0b206125ece, content=<a href='/topic/show?id=097063384db' target=_blank style='color:#2F92EE;'>#死亡负担#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63384, encryptionId=097063384db, topicName=死亡负担)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=263b421, createdName=zhaozuguo, createdTime=Sat May 30 13:19:54 CST 2020, time=2020-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=813721, encodeId=a838813e2139, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=64245268311, createdName=14818eb4m67暂无昵称, createdTime=Thu Aug 27 08:01:25 CST 2020, time=2020-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1830652, encodeId=45c81830652df, content=<a href='/topic/show?id=1b6210686b2' target=_blank style='color:#2F92EE;'>#Lancet#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=10686, encryptionId=1b6210686b2, topicName=Lancet)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3f0227, createdName=howi, createdTime=Sat Jan 30 04:19:54 CST 2021, time=2021-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1629910, encodeId=ce4616299100d, content=<a href='/topic/show?id=b7645849e55' target=_blank style='color:#2F92EE;'>#新生儿死亡#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=58497, encryptionId=b7645849e55, topicName=新生儿死亡)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=450321383666, createdName=charleshjw, createdTime=Sun May 24 03:19:54 CST 2020, time=2020-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1033794, encodeId=98281033e9485, content=顶刊就是不一样,质量很高,内容精彩!学到很多, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=goodbing, createdTime=Fri May 22 15:19:54 CST 2020, time=2020-05-22, status=1, ipAttribution=)]
    2020-05-22 goodbing

    顶刊就是不一样,质量很高,内容精彩!学到很多

    0

相关资讯

印度改变新冠治愈出院标准:中轻度患者症状缓解后无需检测

当地时间8日,印度卫生部修改了新冠肺炎治愈病人的出院政策。根据新的出院政策,只有那些患有严重疾病或免疫力受损的患者才需要在出院前通过核酸检测,确认为阴性后才可以出院。而那些中轻度或非常轻度症状的病例,

4月19日全球新冠肺炎疫情简报,确诊近233万例,接下最担心的是非洲和印度

美国约翰斯·霍普金斯大学发布的实时统计数据显示,截至北京时间4月19日6时30分左右,全球累计确诊新冠肺炎病例2317759例,累计死亡159510例。昨日报道:4月18日全新新冠肺炎疫

印度主张客观理性评估疫情,对中国战胜困难充满信心

2020年1月31日,国务委员兼外交部长王毅应约同印度外长苏杰生通电话。苏杰生表示,印度支持中国政府和人民全力抗击新型冠状病毒疫情,赞赏中方在应对疫情中表现出的公开透明和负责任态度,对中国最终战胜疫情充满信心。王毅感谢印方的支持,表示中国政府和人民正在全力以赴同新型冠状病毒疫情做斗争。我们采取了最全面、最严格的防控举措,很多措施远远超出《国际卫生条例》的要求。中国的努力不仅是在保护本国人民的健康,

新型冠状病毒爆发导致印度的出口限制,引发了人们对全球药品短缺的担忧

随着对COVID-19冠状病毒的爆发,印度决定限制26种活性药物成分(API)和制剂的出口,该决定引起了全球对于药品短缺的担忧。

美媒刊文:特朗普指望印度,印度依赖中国

美国的进口不仅取决于印度的出售意愿,还有赖于印度供货商能否确保从中国获得生产该药品的原料。

全球疫报:4月14日:下一个疫情中心?印度20天确诊人数暴增20倍

截至今天,全球累计确诊病例超过192万例。

Baidu
map
Baidu
map
Baidu
map